Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Bicycle Therapeutics plc (NASDAQ: BCYC), a pioneering entity in the biotechnology sector, presents a compelling opportunity for investors seeking substantial growth in the healthcare industry. With its headquarters in Cambridge,..
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is capturing the attention of investors with a compelling potential upside of 248%. As a commercial-stage biopharmaceutical company, Syndax focuses on the development of innovative..
Cross Country Healthcare, Inc. (NASDAQ: CCRN) is making waves in the healthcare industry, specifically within the medical care facilities sector. With a market capitalization of $404.63 million, this U.S.-based company..
Butterfly Network, Inc. (NASDAQ: BFLY) has been gaining traction in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $443.46 million, this Burlington, Massachusetts-based company..
Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector, is renowned for its innovative contributions to the medical devices industry. With a market capitalization of $446.15 million, the..
Investors navigating the dynamic field of biotechnology would do well to keep an eye on Sage Therapeutics, Inc. (NASDAQ: SAGE), a company specialized in brain health medicines. At a glance,..
Owens & Minor, Inc. (NYSE: OMI), a key player in the healthcare sector, particularly within the medical distribution industry, offers a blend of opportunities and challenges for investors. With a..
For investors with a keen eye on the healthcare sector, particularly biotechnology, Celcuity Inc. (NASDAQ: CELC) represents a compelling opportunity. The Minnesota-based clinical-stage biotech company is currently focused on innovative..
For biotechnology investors seeking promising opportunities in the healthcare sector, Maze Therapeutics, Inc. (NASDAQ: MAZE) presents an intriguing proposition with a notable potential upside of 59.85%. This clinical-stage biopharmaceutical company,..
Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA) is a compelling entity in the biotechnology industry, offering a unique proposition with its cell engineering and biosecurity solutions. As the company continues to..
MeiraGTx Holdings plc (NASDAQ: MGTX) has emerged as a captivating player in the biotechnology sector, capturing the attention of investors with its promising pipeline of gene therapy treatments and a..
Sana Biotechnology, Inc. (NASDAQ: SANA) is making waves in the biotechnology sector, with a market capitalization of $918.01 million. As a company focused on the innovative use of engineered cells..
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a promising player in the biotechnology sector, is capturing the attention of investors with its robust pipeline and a striking potential upside of 186.55%. Headquartered..
Theravance Biopharma, Inc. (NASDAQ: TBPH), a dynamic player in the biotechnology sector, has been garnering attention from investors seeking substantial growth potential in the healthcare industry. The company, with a..
Investors with a keen interest in biotechnology and healthcare are no strangers to the speculative nature of investing in clinical-stage biopharmaceutical companies. Opthea Limited (NASDAQ: OPT), headquartered in South Yarra,..
For investors with an appetite for high-risk, high-reward opportunities, Cel-Sci Corporation (NASDAQ: CVM) presents a compelling case. Operating within the healthcare sector and more specifically, the biotechnology industry, Cel-Sci is..
Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology company, is drawing significant attention from investors with its innovative approach to precision medicine and a striking potential upside of 194.36%. Headquartered..
For investors eyeing opportunities in the healthcare sector, Myriad Genetics, Inc. (NASDAQ: MYGN) presents a compelling case with its molecular diagnostic offerings. Despite facing challenges, the company’s strategic positioning in..
CorMedix Inc. (NASDAQ: CRMD), a key player in the biotechnology sector, is garnering attention from investors with an impressive potential upside of 62.25%. This biopharmaceutical company, headquartered in Berkeley Heights,..
Trevi Therapeutics, Inc. (NASDAQ: TRVI) is capturing significant attention in the biotechnology sector, thanks to its impressive potential upside of 231%. This clinical-stage biopharmaceutical company is dedicated to developing innovative..
